{"id":454858,"date":"2021-03-10T09:18:08","date_gmt":"2021-03-10T14:18:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454858"},"modified":"2021-03-10T09:18:08","modified_gmt":"2021-03-10T14:18:08","slug":"cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","title":{"rendered":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis"},"content":{"rendered":"

<\/p>\n

Cybin to Present at the Stifel GMP Healthcare Conference \u2013 <\/b>Healthcare Psychedelics: Addressing the Global Mental Health Crisis<\/b><\/p>\n

TORONTO–(BUSINESS WIRE<\/a>)–Cybin<\/a> Inc. (NEO:CYBN<\/a>) (OTCQB:CLXPF) (\u201cCybin<\/b>\u201d or the \u201cCompany<\/b>\u201d), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a business and pipeline update at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis as follows:\n<\/p>\n\n\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nThursday, March 11, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n1:00PM Eastern Time\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

https:\/\/wsw.com\/admin\/link\/presenter.aspx?444869985<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nThe presentation will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above.\n<\/p>\n

About Cybin<\/b><\/p>\n

\nCybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.\n<\/p>\n

About Stifel<\/b><\/p>\n

\nStifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel\u2019s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC and Century Securities Associates, Inc. The Company\u2019s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company\u2019s website at www.stifel.com<\/a>. For global disclosures, please visit www.stifel.com\/investor-relations\/press-releases<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210310005568\/en\/<\/a><\/span><\/p>\n

Investors:
\n<\/b>
Tim Regan\/Scott Eckstein
\n
KCSA Strategic Communications
\n
Cybin@kcsa.com<\/a><\/p>\n

\nLisa M. Wilson
\n
In-Site Communications, Inc.
\n
lwilson@insitecony.com<\/a><\/p>\n

Media<\/b>:
\n
John Kanakis
\n
Cybin Inc.
\n
John@cybin.com<\/a><\/p>\n

\nAnnie Graf
\n
KCSA Strategic Communications
\n
agraf@kcsa.com<\/a><\/p>\n

\nFaith Pomeroy-Ward
\n
In-Site Communications, Inc.
\n
Faith@insitecony.com<\/a><\/p>\n

KEYWORDS:<\/b> North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research Banking General Health Professional Services Pharmaceutical Mental Health Science Biotechnology Alternative Medicine Finance Other Science Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (\u201cCybin\u201d or the \u201cCompany\u201d), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a business and pipeline update at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis as follows: Date: \u00a0 Thursday, March 11, 2021 Time: \u00a0 1:00PM Eastern Time Webcast: \u00a0 https:\/\/wsw.com\/admin\/link\/presenter.aspx?444869985 The presentation will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above. About Cybin Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug … <\/p>\n

Continue reading “Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454858","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (\u201cCybin\u201d or the \u201cCompany\u201d), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a business and pipeline update at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis as follows: Date: \u00a0 Thursday, March 11, 2021 Time: \u00a0 1:00PM Eastern Time Webcast: \u00a0 https:\/\/wsw.com\/admin\/link\/presenter.aspx?444869985 The presentation will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above. About Cybin Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug … Continue reading "Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T14:18:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis\",\"datePublished\":\"2021-03-10T14:18:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"},\"wordCount\":390,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\",\"name\":\"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-03-10T14:18:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","og_locale":"en_US","og_type":"article","og_title":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","og_description":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (\u201cCybin\u201d or the \u201cCompany\u201d), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting a business and pipeline update at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis as follows: Date: \u00a0 Thursday, March 11, 2021 Time: \u00a0 1:00PM Eastern Time Webcast: \u00a0 https:\/\/wsw.com\/admin\/link\/presenter.aspx?444869985 The presentation will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above. About Cybin Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug … Continue reading \"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T14:18:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis","datePublished":"2021-03-10T14:18:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"},"wordCount":390,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/","name":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-03-10T14:18:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210310005568r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-present-at-the-stifel-gmp-healthcare-conference-healthcare-psychedelics-addressing-the-global-mental-health-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cybin to Present at the Stifel GMP Healthcare Conference \u2013 Healthcare Psychedelics: Addressing the Global Mental Health Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454858"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}